Investments & Advisories

A digital companion app for psychedelic therapy.

Immunis is a clinical-stage biotech company developing multi-active biologics with immune modulating factors that can address age-related diseases and immune dysregulation.

An intelligent, clinically accurate HRV wearable device for mental health.

MindMed discovers and develops psychedelics inspired medicine.

AI solutions for healthcare operators

Focused on anxiety, depression and dementia, Psy is working to meaningfully improve neuropsychiatric care.

Fully integrated, pre-clinical stage biotechnology company developing therapeutics for the accessible treatment of psychiatric diseases.

ProNovo Therapeutics, leveraging emerging science and cutting-edge technology, to develop novel, precision therapeutics to address urgent unmet needs in the treatment of neuropsychiatric disorders such as Major Depressive Disorder and Schizophrenia.

Reimagines psychoactive natural products as the building blocks for the next generation of neurological products

Early-stage business incubator and accelerator focusing exclusively on the Psychedelic sector.

Tactogen is a public benefit company developing a next generation of mental wellness medicines.

An award-winning breakthrough wellness platform